Application 016455
- Type
- NDA
- Sponsor
- ALMIRALL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CORDRAN | FLURANDRENOLIDE | TAPE;TOPICAL | 0.004MG/SQ CM | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N016455-001 | CORDRAN | FLURANDRENOLIDE | 0.004MG/SQ CM | TAPE / TOPICAL | RLD, RS, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | N016455-001 | CORDRAN | 0.004MG/SQ CM | TAPE / TOPICAL | RLD, RS, Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N016455-001 | CORDRAN | 0.004MG/SQ CM | TAPE / TOPICAL | RLD, RS, Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N016455-001 | CORDRAN | 0.004MG/SQ CM | TAPE / TOPICAL | RLD, RS, Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CORDRAN | FLURANDRENOLIDE | Almirall, LLC | 837a7b23-ab14-4f23-873d-bdee95177691 | 2025-06-23 | Adverse reactions | 016455 NDA016455 16110-587 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0023-5870 | Cordran | Flurandrenolide | Allergan, Inc. | NDA | Current |
| 0023-5870 | Cordran | Flurandrenolide | Allergan, Inc. | NDA | Current |
| 16110-587 | CORDRAN | flurandrenolide | Almirall, LLC | NDA | Current |
| 16110-587 | CORDRAN | flurandrenolide | Almirall, LLC | NDA | Current |
| 16110-587 | CORDRAN | flurandrenolide | Almirall, LLC | NDA | Current |